Immediate Impact

43 standout
Sub-graph 1 of 22

Citing Papers

Multiple myeloma
2024 Standout
Glioblastoma Therapy: Past, Present and Future
2024 Standout
2 intermediate papers

Works of Marcus Blaum being referenced

The Use of O-(2-18F-Fluoroethyl)-l-Tyrosine PET for Treatment Management of Bevacizumab and Irinotecan in Patients with Recurrent High-Grade Glioma: A Cost-Effectiveness Analysis
2013
Multidetector CT of the Spine in Multiple Myeloma: Comparison with MR Imaging and Radiography
2002

Author Peers

Author Last Decade Papers Cites
Marcus Blaum 48 99 93 95 10 329
Peter Greenberg 34 82 68 179 10 368
Benedikt Wagner 28 69 56 118 19 271
M. Bamberg 83 132 59 35 10 337
Marcus M. Kessler 18 100 62 80 12 359
Janet I. Malowany 31 55 45 159 10 330
F. S. Grebbell 79 106 71 63 8 278
Dieter H. Graessle 90 61 246 66 10 362
Giovanni Frezza 56 100 59 28 16 321
Stefan Bruijnen 31 56 78 22 14 338
Todd Barnett 62 68 73 160 11 326

All Works

Loading papers...

Rankless by CCL
2026